Recent Quarter Total Invested
$2.89 B
Recent Quarter Institutional Ownership Percentage
95.51%
Total Invested of Last Quarter
$3.16 B
Ownership Percentage of Last Quarter
94.62%
Xenon Pharmaceuticals Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BOONE CAPITAL MANAGEMENT LLC | 08/14/2024 | 250,460 | $9.77 M | -14.05% | 0.32% |
DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 273,739 | $10.67 M | 0.00% | 0.35% |
ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 291,868 | $11.38 M | 22.20% | 0.38% |
FIRST TURN MANAGEMENT, LLC | 08/08/2024 | 339,876 | $13.25 M | -50.05% | 0.44% |
VANGUARD GROUP INC | 08/13/2024 | 341,152 | $13.30 M | 1.64% | 0.44% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 357,178 | $13.93 M | 131.88% | 0.46% |
ALTIUM CAPITAL MANAGEMENT LP | 08/15/2024 | 360,600 | $14.06 M | 3.62% | 0.46% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 364,173 | $14.20 M | 21.48% | 0.47% |
LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 375,000 | $14.62 M | 100.00% | 0.48% |
ARTAL GROUP S.A. | 08/14/2024 | 381,554 | $14.88 M | 50.58% | 0.49% |
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 07/30/2024 | 421,121 | $16.42 M | 1.05% | 0.54% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 436,460 | $17.01 M | 6.40% | 0.56% |
POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 482,022 | $18.79 M | 74.73% | 0.62% |
CANDRIAM S.C.A. | 08/05/2024 | 521,836 | $20.35 M | -6.96% | 0.67% |
VESTAL POINT CAPITAL, LP | 08/14/2024 | 525,000 | $20.47 M | 31.25% | 0.68% |
JENNISON ASSOCIATES LLC | 08/05/2024 | 570,272 | $22.23 M | 1.12% | 0.73% |
FRANKLIN RESOURCES INC | 08/14/2024 | 578,865 | $22.57 M | 6.74% | 0.75% |
FIERA CAPITAL CORP | 08/19/2024 | 582,879 | $22.73 M | 1.10% | 0.75% |
PERCEPTIVE ADVISORS LLC | 08/16/2024 | 583,256 | $22.74 M | -34.63% | 0.75% |
BOXER CAPITAL, LLC | 08/14/2024 | 600,000 | $23.39 M | 0.00% | 0.77% |
SAMLYN CAPITAL, LLC | 08/14/2024 | 639,685 | $24.94 M | 61.46% | 0.82% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 08/14/2024 | 643,546 | $25.09 M | 85.27% | 0.83% |
LOOMIS SAYLES & CO L P | 08/13/2024 | 660,258 | $25.74 M | -3.82% | 0.85% |
FEDERATED HERMES, INC. | 08/08/2024 | 734,555 | $28.64 M | -0.05% | 0.95% |
AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 754,000 | $29.40 M | 6.20% | 0.97% |
TIMESSQUARE CAPITAL MANAGEMENT, LLC | 08/08/2024 | 754,493 | $29.42 M | 2.35% | 0.97% |
CITADEL ADVISORS LLC | 08/14/2024 | 768,726 | $29.97 M | -40.27% | 0.99% |
ORBIMED ADVISORS LLC | 08/14/2024 | 862,362 | $33.62 M | 56.79% | 1.11% |
INVESCO LTD. | 08/13/2024 | 866,785 | $33.80 M | -17.41% | 1.12% |
BAKER BROS. ADVISORS LP | 08/14/2024 | 993,679 | $38.74 M | 0.00% | 1.28% |
AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 994,227 | $38.76 M | 18.73% | 1.28% |
JANUS HENDERSON GROUP PLC | 08/14/2024 | 1.05 M | $40.77 M | 11.01% | 1.35% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2024 | 1.27 M | $49.63 M | 1.38% | 1.64% |
FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2024 | 1.31 M | $50.93 M | -1.05% | 1.68% |
MARSHALL WACE, LLP | 08/14/2024 | 1.38 M | $53.99 M | -4.53% | 1.78% |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.44 M | $56.14 M | 0.95% | 1.86% |
PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 1.48 M | $57.68 M | -2.37% | 1.91% |
ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.48 M | $57.83 M | 1.00% | 1.91% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 1.84 M | $71.72 M | 10.03% | 2.37% |
PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 2.04 M | $79.67 M | -17.77% | 2.63% |
BLACKROCK INC. | 08/13/2024 | 2.10 M | $81.72 M | -1.23% | 2.70% |
CAPITAL INTERNATIONAL INVESTORS | 08/13/2024 | 2.48 M | $96.53 M | 0.00% | 3.19% |
POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 2.54 M | $98.88 M | -2.91% | 3.27% |
BRAIDWELL LP | 08/14/2024 | 2.56 M | $99.84 M | 95.76% | 3.30% |
CAPITAL WORLD INVESTORS | 08/13/2024 | 2.68 M | $104.55 M | 0.00% | 3.46% |
COMMODORE CAPITAL LP | 08/14/2024 | 2.75 M | $107.39 M | 27.05% | 3.55% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 3.83 M | $149.26 M | -2.39% | 4.93% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 4.42 M | $172.32 M | 2.26% | 5.70% |
AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 5.67 M | $220.94 M | 0.00% | 7.30% |
FMR LLC | 08/13/2024 | 6.77 M | $263.89 M | 2.52% | 8.72% |
Xenon Pharmaceuticals Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of XENE shares?
During the previous two years, 253 institutional investors and hedge funds held shares of Xenon Pharmaceuticals Inc.. The most heavily invested institutionals were:
FMR LLC: 6.77 M
Avoro Capital Advisors LLC: 5.67 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 4.42 M
WELLINGTON MANAGEMENT GROUP LLP: 3.83 M
COMMODORE CAPITAL LP: 2.75 M
Capital World Investors: 2.68 M
-
What percentage of Xenon Pharmaceuticals Inc. stock is owned by institutional investors?
95.51% of Xenon Pharmaceuticals Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at XENE ?
Institutional investors have bought a total of 77.12 M shares in the last 24 months. This purchase volume represents approximately $3.13 B in transactions.